$EVER Cashflow Statement | Understand Stock

$EVER

$21.47 -$0.89 (3.98%) Close

$EVER Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization expense
Stock-based compensation expense
Deferred taxes
Loss on sale of health assets
Impairment of right-of-use asset
Change in fair value of contingent consideration liabilities
Provision for bad debt
Unrealized foreign currency transaction (gains) losses
Litigation accrual settled with sale of assets
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Commissions receivable, current and non-current
Operating lease right-of-use assets
Other assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Operating lease liabilities
Other long-term liabilities

Net cash provided by (used in) operating activities
Cash flows from investing activities:
Acquisition of property and equipment, including costs capitalized for development of internal-use software
Proceeds from sale of health assets
Acquisition of business
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from exercise of stock options
Repurchase of common stock
Proceeds from private placement of common stock
Tax withholding payments related to net share settlement
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash paid for income taxes
Supplemental disclosure of noncash investing and financing information:
Acquisition of property and equipment included in accounts payable
Fair value of contingent consideration in connection with acquisition included in other long-term liabilities
Fair value of contingent consideration in connection with acquisition included in liabilities
Assets sold in settlement of litigation accrual
Issuance of Class A common stock
Settle Contingent Consideration Liability
Settlement of Stock-Based Compensation Liability
Operating lease liabilities arising from obtaining right-of-use assets

Cash and cash equivalents
Restricted cash (included in other assets)

Comments